Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesenchymal Stem Cells in Advanced COPD
NCT04047810Phase 1Completed
- Sponsor
- Mayo Clinic
- Start
- Jan 2020
- Primary completion
- Nov 2023
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of mesenchymal stem cells in chronic obstructive pulmonary disease (COPD), sponsored by Mayo Clinic. Primary endpoint: Adverse Events. Started Jan 2020; status: completed.
02
Drugs
mesenchymal stem cells
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT04047810.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04047810.